<?xml version="1.0" encoding="UTF-8"?>
<p>In summary, Zika vaccine development continues with multiple candidate vaccines in clinical trials. Because of the significant decline in incidence, evaluation of vaccine efficacy is increasingly difficult. There has been renewed interest in animal model and human infection models of infection.</p>
